{"transactions":[{"id":695761,"issuer":{"id":4623,"kind":"organization","name":"Fortrea Holdings Inc.","symbol":"FTRE"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-05T20:04:21.000Z","date":"2026-08-03","kind":"sale","planned":false,"acquired":false,"shares":9700,"price":18.01,"value":174697.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The sales reported on this Form 4 represent shares of Common Stock sold by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number reflects the aggregate amount of Common Stock held by the reporting person."}],"balance_after":36399,"source":{"system":"sec-edgar","filing":"0001965040-26-000111","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000196504026000111/form4.xml","form_type":"4"}},{"id":738602,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:14:41.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000043","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000043/form4.xml","form_type":"4"}},{"id":738601,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:14:41.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":45936,"source":{"system":"sec-edgar","filing":"0000882796-26-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000043/form4.xml","form_type":"4"}},{"id":739890,"issuer":{"id":4623,"kind":"organization","name":"Fortrea Holdings Inc.","symbol":"FTRE"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-06-12T20:18:11.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":12852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. (\"Fortrea\") common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents a RSU award that vests in its entirety twelve months after June 10, 2026, subject to the Reporting Person's continued service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents a RSU award that vests in its entirety twelve months after June 10, 2026, subject to the Reporting Person's continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"This number reflects the aggregate number of RSUs held by the reporting person."}],"balance_after":12852,"derivative":{"underlying":"Common Stock","underlying_shares":12852},"source":{"system":"sec-edgar","filing":"0001965040-26-000086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000196504026000086/form4.xml","form_type":"4"}},{"id":739889,"issuer":{"id":4623,"kind":"organization","name":"Fortrea Holdings Inc.","symbol":"FTRE"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-06-12T20:18:11.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":38817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. (\"Fortrea\") common stock (\"Common Stock\"). This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an RSU award that vested in its entirety on June 10, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents an RSU award that vested in its entirety on June 10, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":38817},"source":{"system":"sec-edgar","filing":"0001965040-26-000086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000196504026000086/form4.xml","form_type":"4"}},{"id":739888,"issuer":{"id":4623,"kind":"organization","name":"Fortrea Holdings Inc.","symbol":"FTRE"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-12T20:18:11.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":38817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. (\"Fortrea\") common stock (\"Common Stock\"). This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number reflects the aggregate amount of Common Stock held by the reporting person."}],"balance_after":46099,"source":{"system":"sec-edgar","filing":"0001965040-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000196504026000086/form4.xml","form_type":"4"}},{"id":998318,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-17T21:07:08.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":9600,"price":7.14,"value":68544.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a plan adopted by the Reporting Person on August 14, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale occurred automatically and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":30642,"source":{"system":"sec-edgar","filing":"0000882796-25-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000017/form4.xml","form_type":"4"}},{"id":1110482,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Automatic Stock Option Grant","published_at":"2025-06-16T20:22:22.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":27181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":27181,"derivative":{"exercise_price":10.4,"exercise_date":"2026-06-12","expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":27181},"source":{"system":"sec-edgar","filing":"0001171843-25-003918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003918/ownership.xml","form_type":"4"}},{"id":1110481,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:22:22.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":40242,"source":{"system":"sec-edgar","filing":"0001171843-25-003918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003918/ownership.xml","form_type":"4"}},{"id":1113498,"issuer":{"id":4623,"kind":"organization","name":"Fortrea Holdings Inc.","symbol":"FTRE"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-06-13T00:18:10.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":38817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a RSU award that vests in its entirety twelve months after June 10, 2025, subject to the Reporting Person's continued service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents a RSU award that vests in its entirety twelve months after June 10, 2025, subject to the Reporting Person's continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of RSUs held by the reporting person."}],"balance_after":38817,"derivative":{"underlying":"Common Stock","underlying_shares":38817},"source":{"system":"sec-edgar","filing":"0001127602-25-017404","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000112760225017404/form4.xml","form_type":"4"}},{"id":1145439,"issuer":{"id":4623,"kind":"organization","name":"Fortrea Holdings Inc.","symbol":"FTRE"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-05-16T20:45:07.000Z","date":"2025-05-14","kind":"exercise","planned":false,"acquired":false,"shares":7282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. (\"Fortrea\") Common Stock. This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an RSU award that vested in its entirety on May 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents an RSU award that vested in its entirety on May 14, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7282},"source":{"system":"sec-edgar","filing":"0001127602-25-014734","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000112760225014734/form4.xml","form_type":"4"}},{"id":1145438,"issuer":{"id":4623,"kind":"organization","name":"Fortrea Holdings Inc.","symbol":"FTRE"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-16T20:45:07.000Z","date":"2025-05-14","kind":"exercise","planned":false,"acquired":true,"shares":7282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. (\"Fortrea\") Common Stock. This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number reflects the aggregate amount of Common Stock held by the reporting person."}],"balance_after":7282,"source":{"system":"sec-edgar","filing":"0001127602-25-014734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000112760225014734/form4.xml","form_type":"4"}},{"id":1478005,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T20:31:05.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":4689,"price":6,"value":28134.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold with the sole purpose of generating sufficient proceeds to cover the tax liability incurred in connection with the vesting of 16,745 Restricted Stock Units on June 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.99 to $6.01. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":27742,"source":{"system":"sec-edgar","filing":"0001127602-24-018846","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224018846/form4.xml","form_type":"4"}},{"id":1479837,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2024-06-14T20:33:44.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":49933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":49933,"derivative":{"exercise_price":6.3,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":49933},"source":{"system":"sec-edgar","filing":"0001127602-24-018737","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224018737/form4.xml","form_type":"4"}},{"id":1479836,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:33:44.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":32431,"source":{"system":"sec-edgar","filing":"0001127602-24-018737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224018737/form4.xml","form_type":"4"}},{"id":1514316,"issuer":{"id":4623,"kind":"organization","name":"Fortrea Holdings Inc.","symbol":"FTRE"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2024-05-16T20:40:28.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":7282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive one share of Fortrea Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a RSU award that vests in its entirety twelve months after May 14, 2024, subject to the Reporting Person's continued service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents a RSU award that vests in its entirety twelve months after May 14, 2024, subject to the Reporting Person's continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of RSUs held by the reporting person."}],"balance_after":7282,"derivative":{"underlying":"Common Stock","underlying_shares":7282},"source":{"system":"sec-edgar","filing":"0001127602-24-015696","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000112760224015696/form4.xml","form_type":"4"}},{"id":1843483,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-27T22:30:05.000Z","date":"2023-06-27","kind":"sale","planned":false,"acquired":false,"shares":11553,"price":0.4082,"value":4715.9346,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy tax obligations of the Reporting Person incurred upon the vesting and settlement of certain restricted stock units that vested on June 7, 2023."}],"balance_after":25248,"source":{"system":"sec-edgar","filing":"0001467154-23-000073","document":"wf-form4_168790499279589.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715423000073/wf-form4_168790499279589.xml","form_type":"4"}},{"id":1855064,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2023-06-15T20:37:27.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":39072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":39072,"derivative":{"exercise_price":8.18,"exercise_date":"2024-06-13","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":39072},"source":{"system":"sec-edgar","filing":"0001127602-23-018783","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018783/form4.xml","form_type":"4"}},{"id":1855063,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:37:27.000Z","date":"2023-06-15","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":7.98,"value":31920.0,"ownership":{"direct":true},"balance_after":25611,"source":{"system":"sec-edgar","filing":"0001127602-23-018783","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018783/form4.xml","form_type":"4"}},{"id":1855062,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:37:27.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":16745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":29611,"source":{"system":"sec-edgar","filing":"0001127602-23-018783","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018783/form4.xml","form_type":"4"}},{"id":1862433,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-09T01:21:58.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":false,"shares":36101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs fully vested on June 7, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs fully vested on June 7, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":36101},"source":{"system":"sec-edgar","filing":"0001467154-23-000063","document":"wf-form4_168627370772603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715423000063/wf-form4_168627370772603.xml","form_type":"4"}},{"id":1862432,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-09T01:21:58.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":103092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service as of the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service as of the vesting date."}],"balance_after":103092,"derivative":{"underlying":"Common Stock","underlying_shares":103092},"source":{"system":"sec-edgar","filing":"0001467154-23-000063","document":"wf-form4_168627370772603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715423000063/wf-form4_168627370772603.xml","form_type":"4"}},{"id":1862431,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T01:21:58.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":true,"shares":36101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") on June 7, 2022. Each RSU represented a contingent right to receive one share of the Issuer's Common Stock. 36,101 RSUs fully vested on June 7, 2023 and were settled in shares of the Issuer's Common Stock."}],"balance_after":36801,"source":{"system":"sec-edgar","filing":"0001467154-23-000063","document":"wf-form4_168627370772603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715423000063/wf-form4_168627370772603.xml","form_type":"4"}},{"id":2185676,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-15T20:19:46.000Z","date":"2022-08-15","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":3.6,"value":36000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-028647","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000089924322028647/doc4.xml","form_type":"4"}},{"id":2185675,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-15T20:19:46.000Z","date":"2022-08-15","kind":"disposition_to_issuer","acquired":false,"shares":5500,"price":10,"value":55000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Merger Agreement, as of the Effective Time, these shares were converted into the right to receive the consideration per Share of (i) $10.00, payable to the holder thereof of cash, without interest but subject to reduction for any applicable withholding Taxes payable in respect thereof, and (ii) one CVR per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Merger Agreement, as of the Effective Time, these shares were converted into the right to receive the consideration per Share of (i) $10.00, payable to the holder thereof of cash, without interest but subject to reduction for any applicable withholding Taxes payable in respect thereof, and (ii) one CVR per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-028647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000089924322028647/doc4.xml","form_type":"4"}},{"id":2237859,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-09T21:28:09.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":36101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") as the annual award made on the annual meeting date pursuant to the terms of the Issuer's Non-Employee Director Compensation Policy, and each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs."}],"balance_after":36101,"derivative":{"underlying":"Common Stock","underlying_shares":36101},"source":{"system":"sec-edgar","filing":"0001467154-22-000097","document":"wf-form4_165481007467241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715422000097/wf-form4_165481007467241.xml","form_type":"4"}},{"id":2238393,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2022-06-09T20:53:09.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":30022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":30022,"derivative":{"exercise_price":10.79,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":30022},"source":{"system":"sec-edgar","filing":"0001127602-22-017169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222017169/form4.xml","form_type":"4"}},{"id":2238392,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-09T20:53:09.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":12866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":12866,"source":{"system":"sec-edgar","filing":"0001127602-22-017169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222017169/form4.xml","form_type":"4"}},{"id":2405159,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-02-10T22:06:28.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":26667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 1/36 per month for a period of 36 months, beginning on March 8, 2022."}],"balance_after":26667,"derivative":{"exercise_price":17.2,"expiration_date":"2032-02-08","underlying":"Common Stock","underlying_shares":26667},"source":{"system":"sec-edgar","filing":"0001171843-22-000942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184322000942/ownership.xml","form_type":"4"}},{"id":2426766,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-25T21:31:01.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the grant date, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":6.4,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-004789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000120919122004789/doc4.xml","form_type":"4"}},{"id":2426765,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-25T21:31:01.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on the first anniversary of the award date, subject to continued service with RDUS through such date."}],"balance_after":5500,"source":{"system":"sec-edgar","filing":"0001209191-22-004789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000120919122004789/doc4.xml","form_type":"4"}},{"id":2691375,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-28T20:57:54.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":8923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, with the first installment vesting on August 26, 2021."}],"balance_after":8923,"derivative":{"exercise_price":9.19,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":8923},"source":{"system":"sec-edgar","filing":"0001467154-21-000091","document":"wf-form4_162223545116836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715421000091/wf-form4_162223545116836.xml","form_type":"4"}},{"id":2725175,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-06T20:39:28.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, with the first installment vesting on August 4, 2021."}],"balance_after":35000,"derivative":{"exercise_price":1.29,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001467154-21-000053","document":"wf-form4_162033353760459.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715421000053/wf-form4_162033353760459.xml","form_type":"4"}},{"id":2921010,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T21:34:29.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in substantially equal installments on each of the first four anniversaries of January 4, 2021."}],"balance_after":30000,"derivative":{"exercise_price":18.17,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-001109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000120919121001109/doc4.xml","form_type":"4"}},{"id":3073402,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-31T01:14:58.000Z","date":"2020-07-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, with the first installment vesting on October 28, 2020."}],"balance_after":20000,"derivative":{"exercise_price":0.78,"expiration_date":"2030-07-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001467154-20-000120","document":"wf-form4_159615807796296.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715420000120/wf-form4_159615807796296.xml","form_type":"4"}},{"id":3224698,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2020-03-05T21:16:12.000Z","date":"2020-03-03","kind":"purchase","acquired":true,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The combined price for each share of common stock (disclosed in Table I) and the accompanying warrant was $0.30."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants to purchase 7,000 shares of Common Stock of the Issuer may be exercised at any time prior to the expiration date."}],"balance_after":7000,"derivative":{"exercise_price":0.3,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001467154-20-000028","document":"wf-form4_158344295414435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715420000028/wf-form4_158344295414435.xml","form_type":"4"}},{"id":3224697,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-05T21:16:12.000Z","date":"2020-03-03","kind":"purchase","acquired":true,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The combined price for each share of common stock and the accompanying warrant (disclosed in Table II) was $0.30."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001467154-20-000028","document":"wf-form4_158344295414435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715420000028/wf-form4_158344295414435.xml","form_type":"4"}},{"id":3449283,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T20:18:57.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, with the first installment vesting on October 31, 2019."}],"balance_after":20000,"derivative":{"exercise_price":2.63,"expiration_date":"2029-07-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001467154-19-000061","document":"wf-form4_156477712170196.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000146715419000061/wf-form4_156477712170196.xml","form_type":"4"}},{"id":3901798,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T00:57:13.000Z","date":"2018-06-04","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, with the first installment vesting on September 4, 2018."}],"balance_after":20000,"derivative":{"exercise_price":3.08,"expiration_date":"2028-06-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-036556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000120919118036556/doc4.xml","form_type":"4"}},{"id":4201639,"issuer":{"id":111882,"kind":"organization","name":"Novan, Inc.","symbol":"NOVN"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-26T22:15:11.000Z","date":"2017-09-24","kind":"grant","acquired":true,"shares":19240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments, with the first installment vesting on December 24, 2017 and subsequent installments vesting every three months thereafter, such that the option will be fully vested on September 24, 2018."}],"balance_after":19240,"derivative":{"exercise_price":5.4,"expiration_date":"2027-09-23","underlying":"Common Stock","underlying_shares":19240},"source":{"system":"sec-edgar","filing":"0001209191-17-054047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718020/000120919117054047/doc4.xml","form_type":"4"}}]}